Gut Microbiota and Integrative Traditional Chinese and Western Medicine in Prevention and Treatment of Heart Failure
Herong Cui,Songjie Han,Yanan Dai,Wei Xie,Rui Zheng,Yang Sun,Xiaofeng Xia,Xiaopeng Deng,Yaru Cao,Mei Zhang,Hongcai Shang
DOI: https://doi.org/10.1016/j.phymed.2023.154885
IF: 6.656
2023-05-24
Phytomedicine
Abstract:Background Heart failure (HF) is the terminal stage of multiple cardiovascular diseases, with high mortality and morbidity. More and more studies have proved that gut microbiota may play a role in the process of HF, which is expected to become a new therapeutic target. The combination of traditional Chinese and Western medicine has vast therapeutic potential of complementation against HF. Purpose This manuscript expounds on the research progress of mechanisms of gut microbiota participating in the occurrence and prognosis of HF and the role of integrative traditional Chinese and Western medicine from 1987-2022. The combination of traditional Chinese and Western medicine in the prevention and treatment of HF from the perspective of gut microbiota has been discussed. Methods Studies focusing on the effects and their mechanisms of gut microbiota in HF and the role of integrative traditional Chinese and Western medicine were identified and summarized, including contributions from February 1987 until August 2022. The investigation was carried out in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. We searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, and VIP databases up to April 2023 by using the relevant keywords and operators. Results A total of 34 articles were finally included in this review.16 RCTs and 13 basic researches, and 3 clinical research studies involving 7 relevant outcome indicators(cardiac function evaluation index, changes in gut microbiota, inflammatory factors, metabolites of gut microbiota, serum nutritional index protein, quality of life score, intestinal permeability and all-cause mortality).. Compared with healthy controls, serum TNF-α and TMAO levels were significantly higher in patients with heart failure༻MD=5.77, 95%CI(4.97, 6.56), P<0.0001;SMD=1.92, 95%CI(1.70, 2.14), P<0.0001]. Escherichia coli and Thick-walled bacteria increased significantly༻SMD=-0.99, 95%CI(-1.38, -0.61), P<0.0001,SMD=2.58, 95%CI(2.23, 2.93), P<0.0001];The number of bacteroides and lactobacillus decreased༻SMD=-2.29, 95%CI(-2.54, -2.04), P<0.0001;SMD=-1.55, 95%CI(-1.8, -1.3), P<0.0001]. There was no difference in bifidobacterium ༻SMD=0.16, 95%CI(-0.22, 0.54), P=0.42]. In the published literature, it is not difficult to see that most of the results are studied and proved based on animal experiments or clinical trials, involving the cellular level, while the mechanism and mode of action of the molecular biology of traditional Chinese medicine are less elaborated, which is related to the characteristics of multi-components and multi-targets of traditional Chinese medicine. The above are the shortcomings of published literature, which can also be the direction of future research. Conclusion Heart failure patients have decreased beneficial bacteria such as Bacillus mimics and Lactobacillus in the intestinal flora and increased harmful flora like thick-walled flora. And increase the inflammatory response of the body and the expression of trimethylamine oxide (TMAO) in the serum. And The prevention and treatment of integrative traditional Chinese and Western medicine against heart failure based on gut microbiota and its metabolites is a promising research direction.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences